All Type of News
New bio-equivalency standard guideline for 160 active drug ingredients.
The KFDA said on Feb. 22 that the Standard Guideline for Bioequivalency was established for 21 active drug ingredients including aceclofenac and ramipril and others such as clarythromycin, the total 160 ingredients.
...
Drug company stock prices now in brisk aspect.
The leading security companies including Daesin, Hanwha and Goodmorning Shinhan have predicted an optimistic future for the stock prices of major pharmaceutical companies after passing through a long dark tunnel start...
KIFHAD: breaking ground to construct international support center.
The Korea International Foundation for health and development (KIFHAD) took a ground breaking ceremony on Feb. 20 for the construction of a supporting center of medical equipments (hereinafter called Center) in presen...
KPA asked KPMA to compensate on drug price slashes.
The Korea Pharmaceutical Association (KPA) asked the KPMA for the compensation as much as the price differences accrued from the NHI price reduction.
As a result of the government drug price review and the post act...
KFDA/KHIDI jointly operating a Korea-America FTA team.
The KFDA and the Korea Health Industry Development Institute (KHIDI) have agreed to operate a full responsible team for the future Korea and American FTA project to prepare an appropriate measure against diverse issue...
211 clinical test centers were registered in Korea.
The KFDA reported the total 211 as of today, including Seoul National University hospital and 21 centers newly registered last year.
The report revealed 29 centers for the phase I clinical study, 79 centers for the...
NHI reimbursement for Lyrica and 254 new drugs approved.
The NHI reimbursement prices for the total 254 drugs including Pfizer's Lyrica have been newly approved.
The MOHW announced the official notification for the revised NHI price list covering the total 2,475 drug pri...
Dongsung to enter Indian market with hair dyes.
Dongsung has led the hair dye business in Korea and now successfully extended its business to India in association with Kamakhya Inc. under the distribution agreement. They
already made an initial shipment for $30,0...
Maxmarvil sales on the rise with added indications.
Yuyu has changed the label of Maximarvil, an anti-osteoporosis drug, in which the patient may allow to lie down after medication of Maximarvil, which may increase its sales in such a severe market competition with man...
Novartis to launch "Safe BP Zone" in Korea.
"Safe Blood Pressure Zone" program for the world hypertensive patients seems to be launched to Korea too, which was purported for the hypertensive patients to keep a normal blood pressure and thereby better quality of...
